1. Clark, S. and Weale, A. (2012), “Social values in health priority setting: a conceptual framework”, Journal of Health Management and Organisation, Vol. 26 No. 3, pp. 293‐316.
2. Department of Health (2005), “Directions and Consolidating Directions to the National Institute for Health and Clinical Excellence 2005”, available at: www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsLegislation/DH_4109216 (accessed 5 September 2011).
3. Department of Health (2008), “Improving access to medicines for NHS patients: a report for the Secretary of State for Health by Professor Mike Richards CBE”, available at: www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_089952.pdf.
4. Faden, R.R. and Chalkidou, K. (2011), “Determining the value of drugs – the evolving British experience”, New England Journal of Medicine, Vol. 364 No. 14, pp. 1289‐91.
5. Garner, S. et al. (2012), “Reducing ineffective practice: challenges in identifying low‐value healthcare using systematic reviews”, The Journal of Health Services Research and Policy, in press.